Your browser doesn't support javascript.
loading
Various Adjuvants Effect on Immunogenicity of Puumala Virus Vaccine.
Kurashova, Svetlana S; Ishmukhametov, Aidar A; Dzagurova, Tamara K; Egorova, Maria S; Balovneva, Maria V; Nikitin, Nikolai A; Evtushenko, Ekaterina A; Karpova, Olga V; Markina, Anna A; Aparin, Peter G; Tkachenko, Petr E; L Vov, Vyatcheslav L; Tkachenko, Evgeniy A.
Afiliação
  • Kurashova SS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Dzagurova TK; Institute for Translatonal Medicine and Bionechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Egorova MS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Balovneva MV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Nikitin NA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Evtushenko EA; Department of Virology, Lomonosov Moscow State University, Moscow, Russia.
  • Karpova OV; Department of Virology, Lomonosov Moscow State University, Moscow, Russia.
  • Markina AA; Department of Virology, Lomonosov Moscow State University, Moscow, Russia.
  • Aparin PG; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • Tkachenko PE; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
  • L Vov VL; Department of Internal Medicine Propaedeutics, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Tkachenko EA; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia.
Front Cell Infect Microbiol ; 10: 545371, 2020.
Article em En | MEDLINE | ID: mdl-33194793
ABSTRACT
Various adjuvant effects on the immunogenicity of the candidate inactivated Puumala virus vaccine were detected in BALB/c mice. Adjuvants under study were aluminum hydroxide, spherical particles of Tobacco mosaic virus coat protein, B subunit of heat-labile enterotoxin of Escherichia coli, and low endotoxic lipopolysaccharide of Shigella sonnei. Aluminum hydroxide (1 mg/ml) did not affect neutralizing antibodies' induction and vaccine stability during storage compared to immunization with the vaccine without adjuvant. B subunit of heat-labile enterotoxin (0.2 µg/ml), low endotoxic lipopolysaccharide (50 µg/ml), and plant virus-based spherical particles (300 µg/ml) significantly enhance the humoral immune response of vaccine (p < 0.0001). Pronounced stimulation of IL-12 and IFN-É£ was observed when mice were immunized with vaccines both with adjuvants (except of aluminum hydroxide) and without adjuvants. It has been shown that low endotoxic lipopolysaccharide contributes not only to enhance the immune response but also to stabilize vaccine immunogenicity during at least 1 year storage.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Bacterianas / Virus Puumala / Proteínas de Escherichia coli Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Bacterianas / Virus Puumala / Proteínas de Escherichia coli Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article